Page last updated: 2024-10-28

hydroxychloroquine and Degos Disease

hydroxychloroquine has been researched along with Degos Disease in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"We report a case of chronic cutaneous lupus erythematosus in a 41-year-old male presenting with prominent Degos-like skin lesions."1.36Prominent Degos-like skin lesions in a patient with chronic cutaneous lupus erythematosus. ( Mutizwa, MM; Ng, SK; Tang, MB, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vinay, K1
Sawatkar, G1
Dogra, S1
Saikia, UN1
Mutizwa, MM1
Tang, MB1
Ng, SK1

Other Studies

2 other studies available for hydroxychloroquine and Degos Disease

ArticleYear
Systemic lupus erythematosus with Degos disease: role of dermatoscopy in diagnosis.
    International journal of dermatology, 2017, Volume: 56, Issue:7

    Topics: Adolescent; Aspirin; Biopsy, Needle; Dermoscopy; Drug Therapy, Combination; Female; Humans; Hydroxyc

2017
Prominent Degos-like skin lesions in a patient with chronic cutaneous lupus erythematosus.
    Dermatology online journal, 2010, Jul-15, Volume: 16, Issue:7

    Topics: Adult; Antirheumatic Agents; Aspirin; Diagnosis, Differential; Humans; Hydroxychloroquine; Lupus Ery

2010